Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03046446 · ClinicalTrials.gov registry record · Phase 3
Study to Assess the Safety of Repeat Administration of FX006 Administered to Patients With Osteoarthritis of the Knee
A Phase 3 study of Osteoarthritis of the Knee, sponsored by Pacira Pharmaceuticals.
- Completed
- Registry status
- Phase 3
- Development phase
- 208
- Enrollment target
- 17
- Study locations
NCT03046446 is a Phase 3 study of Osteoarthritis of the Knee that has completed, run by Pacira Pharmaceuticals. The registered enrollment target is 208 participants, roughly in line with the 207-participant average among 15 other Osteoarthritis of the Knee trials with a reported enrollment target. The trial reports 17 study locations across 10 states.
The verdict
NCT03046446, a Phase 3 study of Osteoarthritis of the Knee, has completed, sponsored by Pacira Pharmaceuticals.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 208 participants
- Enrollment target
- 17
- Study locations
Study Summary
This is an Open-label Study to Assess the Safety of Repeat Dose of FX006 Administered to Patients with Osteoarthritis (OA) of the Knee
Conditions Studied
Interventions
- DRUG FX006 32 mg
Study Locations (17)
California
- Dream Team Clinical Research - Anaheim
- Hope Clinical Research - Canoga Park
- Cedars-Sinai Medical Center - Los Angeles
- Artemis Institute for Clinical Research - San Diego
- Harbor-UCLA Medical Center - Torrance
Florida
- Tampa Bay Medical Research - Clearwater
- The Andrews Institute - Gulf Breeze
Massachusetts
- Brigham and Women's Hospital - Chestnut Hill
- New England Baptist Hospital - Dedham
South Carolina
- Medical University of South Carolina - Charleston
- Coastal Carolina Research Center - Mt. Pleasant
Arizona
- Tucson Orthopedic - Tucson
Louisiana
- Ochsner Sports Medicine Institute - New Orleans
New York
- Rochester Clinical Research - Rochester
North Carolina
- Duke University - Durham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 208 participants |
| Start Date | 2017-02-20 |
| Est. Completion | 2018-07-19 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03046446
The ClinicalTrials.gov registry entry for NCT03046446 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 208 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 207-participant average among 15 other Osteoarthritis of the Knee trials with a reported enrollment target. The listed sponsor is Pacira Pharmaceuticals, which has 88 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Osteoarthritis of the Knee appearing as the primary indexed condition, and to 1 intervention - of which FX006 32 mg is the first listed.
NCT03046446 reports 17 study locations spanning 10 distinct geographic areas - top geographies include California, Florida, Massachusetts.
Frequently Asked Questions
What is clinical trial NCT03046446 about?
NCT03046446 is a clinical study titled "Study to Assess the Safety of Repeat Administration of FX006 Administered to Patients With Osteoarthritis of the Knee". This is an Open-label Study to Assess the Safety of Repeat Dose of FX006 Administered to Patients with Osteoarthritis (OA) of the Knee
What is the current status of trial NCT03046446?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 208 participants. The study started on 2017-02-20. Estimated completion is 2018-07-19.
What conditions does trial NCT03046446 study?
This clinical trial studies the following conditions: Osteoarthritis of the Knee.
What interventions are being tested in trial NCT03046446?
The interventions under investigation include: FX006 32 mg (DRUG).
Who is sponsoring clinical trial NCT03046446?
This trial is sponsored by Pacira Pharmaceuticals, which has 88 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03046446 being conducted?
This trial has 17 study locations across Arizona, California, Florida, Louisiana, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Osteoarthritis of the Knee
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Pragmatic Trial to Determine the Benefit of Behaviorally Enhanced Exercise Incentives and Corticosteroid Injections in Osteoarthritis of the Knee Marching On for Veterans With Osteoarthritis of the Knee
ACTIVE NOT RECRUITING · Phase 3
-
Study of FX006 for the Treatment of Pain in Patients With Osteoarthritis of the Knee
COMPLETED · Phase 3
-
Extended and Controlled Release Liposomal Formulated Dexamethasone for Chronic Knee OA Pain
COMPLETED · Phase 3
-
Cannabinoid Interactions With Central and Peripheral Pain Mechanisms in Osteoarthritis of the Knee
RECRUITING · Phase 2
-
Bone Marrow Aspirate Concentrate (BMAC) vs Corticosteroid Injection
RECRUITING · NA
-
A 4-week Study to Evaluate the Efficacy and Safety of HP-5000 in Subjects With Knee Osteoarthritis
COMPLETED · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.